Correlation Between Cardio Diagnostics and FibroGen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and FibroGen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and FibroGen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and FibroGen, you can compare the effects of market volatilities on Cardio Diagnostics and FibroGen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of FibroGen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and FibroGen.

Diversification Opportunities for Cardio Diagnostics and FibroGen

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Cardio and FibroGen is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and FibroGen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FibroGen and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with FibroGen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FibroGen has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and FibroGen go up and down completely randomly.

Pair Corralation between Cardio Diagnostics and FibroGen

Given the investment horizon of 90 days Cardio Diagnostics is expected to generate 1.55 times less return on investment than FibroGen. In addition to that, Cardio Diagnostics is 1.49 times more volatile than FibroGen. It trades about 0.08 of its total potential returns per unit of risk. FibroGen is currently generating about 0.18 per unit of volatility. If you would invest  33.00  in FibroGen on September 5, 2024 and sell it today you would earn a total of  8.00  from holding FibroGen or generate 24.24% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cardio Diagnostics Holdings  vs.  FibroGen

 Performance 
       Timeline  
Cardio Diagnostics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Cardio Diagnostics Holdings are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Cardio Diagnostics displayed solid returns over the last few months and may actually be approaching a breakup point.
FibroGen 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in FibroGen are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy technical and fundamental indicators, FibroGen is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Cardio Diagnostics and FibroGen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cardio Diagnostics and FibroGen

The main advantage of trading using opposite Cardio Diagnostics and FibroGen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, FibroGen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FibroGen will offset losses from the drop in FibroGen's long position.
The idea behind Cardio Diagnostics Holdings and FibroGen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Global Correlations
Find global opportunities by holding instruments from different markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings